Abiopharma

🔍 Perry Jennifer Scott (Executive)

Company: BICYCLE THERAPEUTICS PLC (BCYC)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Sold 1,038 shares of Ordinary Shares at $4.91 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,834.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 37 shares of Ordinary Shares at $5.05 per share (Direct)
  Date: 2026-04-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,797.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 333 shares of Ordinary Shares at $5.04 per share (Direct)
  Date: 2026-04-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 92,464.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.88 to $4.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
• F3: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.035 to $5.04 inclusive.